Syneos Health Beheer
Beheer criteriumcontroles 1/4
Syneos Health's CEO is Michelle Keefe, appointed in Apr 2022, has a tenure of 1.42 years. total yearly compensation is $8.89M, comprised of 9.7% salary and 90.3% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth $1.53M. The average tenure of the management team and the board of directors is 2.7 years and 2.3 years respectively.
Belangrijke informatie
Michelle Keefe
Algemeen directeur
US$8.9m
Totale compensatie
Percentage CEO-salaris | 9.7% |
Dienstverband CEO | 1.4yrs |
Eigendom CEO | 0.03% |
Management gemiddelde ambtstermijn | 2.7yrs |
Gemiddelde ambtstermijn bestuur | 2.3yrs |
Recente managementupdates
Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2023 | n/a | n/a | US$71m |
Mar 31 2023 | n/a | n/a | US$148m |
Dec 31 2022 | US$9m | US$862k | US$266m |
Sep 30 2022 | n/a | n/a | US$287m |
Jun 30 2022 | n/a | n/a | US$278m |
Mar 31 2022 | n/a | n/a | US$242m |
Dec 31 2021 | US$2m | US$567k | US$235m |
Sep 30 2021 | n/a | n/a | US$251m |
Jun 30 2021 | n/a | n/a | US$236m |
Mar 31 2021 | n/a | n/a | US$198m |
Dec 31 2020 | US$2m | US$522k | US$193m |
Sep 30 2020 | n/a | n/a | US$192m |
Jun 30 2020 | n/a | n/a | US$187m |
Mar 31 2020 | n/a | n/a | US$195m |
Dec 31 2019 | US$2m | US$550k | US$131m |
Compensatie versus markt: Michelle's total compensation ($USD8.89M) is above average for companies of similar size in the US market ($USD6.59M).
Compensatie versus inkomsten: Michelle's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Michelle Keefe (56 yo)
1.4yrs
Tenure
US$8,889,996
Compensatie
Ms. Michelle Keefe serves as Chief Executive Officer at Syneos Health, Inc since April 29, 2022 and serves as its Director since 2022. She served as President of Medical Affairs and Commercial Solutions fo...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | 1.4yrs | US$8.89m | 0.034% $ 1.5m | |
Chief Operating Officer | 1.4yrs | US$6.04m | 0.018% $ 810.0k | |
General Counsel & Corporate Secretary | 4.8yrs | US$3.52m | 0.014% $ 617.4k | |
Chief Business Officer | 5yrs | US$2.62m | 0.011% $ 502.0k | |
Consultant | less than a year | US$3.19m | 0.039% $ 1.8m | |
Chief Financial Officer | less than a year | geen gegevens | geen gegevens | |
Senior VP of Finance & Chief Accounting Officer | 2.7yrs | geen gegevens | 0.0029% $ 130.6k | |
President of Technology & Data Solutions | 1.4yrs | geen gegevens | geen gegevens | |
Chief Scientific Officer | 7.5yrs | geen gegevens | geen gegevens | |
Chief Information & Digital Officer | 2.8yrs | geen gegevens | geen gegevens | |
Senior Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
Global Head of Corporate Communications & Marketing | 6.1yrs | geen gegevens | geen gegevens |
2.7yrs
Gemiddelde duur
52.5yo
Gemiddelde leeftijd
Ervaren management: SYNH's management team is considered experienced (2.7 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Director | 1.7yrs | US$8.89m | 0.034% $ 1.5m | |
Independent Director | 6.9yrs | US$370.77k | 0.019% $ 865.7k | |
Independent Director | less than a year | US$182.56k | 0% $ 0 | |
Independent Director | 6.9yrs | US$322.77k | 0.019% $ 850.1k | |
Independent Director | 1.7yrs | US$351.39k | 0.0034% $ 150.2k | |
Independent Chairman | 4.8yrs | US$483.27k | 0.022% $ 972.7k | |
Independent Director | 2.3yrs | US$308.52k | 0.0048% $ 213.5k | |
Independent Director | 3.8yrs | US$307.77k | 0.0096% $ 426.2k | |
Independent Director | 1.7yrs | US$369.53k | 0.0034% $ 151.6k |
2.3yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: SYNH's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.